Product Information
GABAPENTIN 100 MG CAPSULE is a generic product labeled by Laurus Labs Limited, priced at $0.0210 per EA under NDC 42385097205. Its NADAC has been published 77 times since Jan 8, 2025.
Strength
100 mg/1
Manufacturer
Laurus Labs LimitedNDC
42385097205
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA217546On Market Since
5/13/2023
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 100 MG CAPSULE has been published 77 times since Jan 8, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0210 per EA |
|---|---|
| All-time high | $0.0233 (Apr 16, 2025) |
| All-time low | $0.0207 (Jan 8, 2025) |
| 52-week high | $0.0223 |
| 52-week low | $0.0210 |
| Median price | $0.0214 |
| Average price | $0.0217 |
| Largest weekly change | +8.0% (Feb 19, 2025) |
| Weeks tracked | 77 |
| Tracking since | Jan 8, 2025 |
Generic Alternatives
The matcher finds 18 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Laurus Labs Limited, is $0.0210 per EA (NDC 42385097205), effective Jun 24, 2026.
How has the price of GABAPENTIN 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 77 weekly CMS publications since Jan 8, 2025.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?
Since Jan 8, 2025, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0207 (Jan 8, 2025) to a high of $0.0233 (Apr 16, 2025), with a median of $0.0214 per EA.
Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?
18 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 100 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 100 MG CAPSULE?
GABAPENTIN 100 MG CAPSULE (NDC 42385097205) is labeled by Laurus Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification